{"id":"https://openalex.org/W4230815642","doi":"https://doi.org/10.1158/1538-7445.sabcs18-ct229","title":"Abstract CT229: Olaparib in patients (pts) with previously treated, homologous recombination repair mutation (HRRm) or homologous recombination deficiency (HRD)-positive advanced cancer: Phase II LYNK-002 study","display_name":"Abstract CT229: Olaparib in patients (pts) with previously treated, homologous recombination repair mutation (HRRm) or homologous recombination deficiency (HRD)-positive advanced cancer: Phase II LYNK-002 study","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W4230815642","doi":"https://doi.org/10.1158/1538-7445.sabcs18-ct229"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs18-ct229","doi":"https://doi.org/10.1158/1538-7445.sabcs18-ct229","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-ct229","pdf_url":null,"source":{"id":"https://openalex.org/S59378366","display_name":"Clinical Trials","issn_l":"1740-7745","issn":["1740-7745","1740-7753"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Trials","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068193017","display_name":"David Michael Hyman","orcid":"https://orcid.org/0000-0001-8150-9762","observed_orcids":["https://orcid.org/0000-0001-8150-9762"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Hyman","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027630636","display_name":"Andrew Eugene Hendifar","orcid":"https://orcid.org/0000-0002-2079-9177","observed_orcids":["https://orcid.org/0000-0002-2079-9177"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Hendifar","raw_affiliation_strings":["Cedars-Sinai Medical Center, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cedars-Sinai Medical Center, Los Angeles, CA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090832721","display_name":"Hyun Cheol Chung","orcid":"https://orcid.org/0000-0002-0920-9471","observed_orcids":["https://orcid.org/0000-0002-0920-9471"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4210160791","display_name":"Yonsei University Health System","ror":"https://ror.org/04sze3c15","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I4210160791"]},{"id":"https://openalex.org/I4405258038","display_name":"Yonsei Cancer Hospital","ror":"https://ror.org/0005vby86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I2799970807","https://openalex.org/I4210160791","https://openalex.org/I4405258038"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Hyun Cheol Chung","raw_affiliation_strings":["Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4210160791","https://openalex.org/I4405258038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018536695","display_name":"Michele Maio","orcid":"https://orcid.org/0000-0002-0323-6321","observed_orcids":["https://orcid.org/0000-0002-0323-6321"]},"institutions":[{"id":"https://openalex.org/I4210134849","display_name":"Azienda Ospedaliera Universitaria Senese","ror":"https://ror.org/02s7et124","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210134849"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Michele Maio","raw_affiliation_strings":["Policlinico Le Scotte, A.O. Universitaria Senese, Senese, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Policlinico Le Scotte, A.O. Universitaria Senese, Senese, Italy","institution_ids":["https://openalex.org/I4210134849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025155327","display_name":"Alexandra F. Leary","orcid":"https://orcid.org/0000-0002-2043-2244","observed_orcids":["https://orcid.org/0000-0002-2043-2244"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Alexandra Leary","raw_affiliation_strings":["Institut Gustave Roussy, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060631720","display_name":"Iben Spanggaard","orcid":"https://orcid.org/0000-0001-5925-2630","observed_orcids":["https://orcid.org/0000-0001-5925-2630"]},"institutions":[{"id":"https://openalex.org/I2802567020","display_name":"Copenhagen University Hospital","ror":"https://ror.org/05bpbnx46","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Iben Spanggaard","raw_affiliation_strings":["University Hospital Copenhagen, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Copenhagen, Copenhagen, Denmark","institution_ids":["https://openalex.org/I2802567020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048675749","display_name":"Joon Whan Rhee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joon Rhee","raw_affiliation_strings":["AstraZeneca, Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, MD","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000371599","display_name":"Matt Marton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matt Marton","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Menghui Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Menghui Chen","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109348433","display_name":"Suba Krishnan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suba Krishnan","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110968082","display_name":"Ronnie Shapira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Ronnie Shapira","raw_affiliation_strings":["Chaim Sheba Medical Center, Ramat Gan, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chaim Sheba Medical Center, Ramat Gan, Israel","institution_ids":["https://openalex.org/I2799810450"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"CT229","last_page":"CT229"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.890999972820282},{"id":"https://openalex.org/keywords/homologous-recombination-deficiency","display_name":"homologous recombination deficiency","score":0.9179999828338623},{"id":"https://openalex.org/keywords/homologous-recombination-repair-mutations","display_name":"homologous recombination repair mutations","score":0.8669999837875366},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8100000023841858},{"id":"https://openalex.org/keywords/brca1-mutation","display_name":"BRCA1 mutation","score":0.5839999914169312},{"id":"https://openalex.org/keywords/brca2-mutation","display_name":"BRCA2 mutation","score":0.9980000257492065},{"id":"https://openalex.org/keywords/loss-of-heterozygosity","display_name":"loss of heterozygosity","score":0.8399999737739563},{"id":"https://openalex.org/keywords/tumor-agnostic-therapy","display_name":"tumor-agnostic therapy","score":0.6679999828338623},{"id":"https://openalex.org/keywords/treatment-response-biomarkers","display_name":"treatment response biomarkers","score":0.4959999918937683},{"id":"https://openalex.org/keywords/platinum-refractory-disease","display_name":"platinum-refractory disease","score":0.6100000143051147},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.34700000286102295}],"concepts":[{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.8861098289489746},{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.8035895824432373},{"id":"https://openalex.org/C156695909","wikidata":"https://www.wikidata.org/wiki/Q3373825","display_name":"Recombination","level":3,"score":0.6014431118965149},{"id":"https://openalex.org/C64894306","wikidata":"https://www.wikidata.org/wiki/Q849622","display_name":"Homologous chromosome","level":3,"score":0.5875167846679688},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.4375850260257721},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3667294979095459},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3524557650089264},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34830737113952637},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3383287787437439},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3164522051811218},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.1726798415184021},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.15380489826202393},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1365361511707306},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0696973204612732}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs18-ct229","doi":"https://doi.org/10.1158/1538-7445.sabcs18-ct229","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-ct229","pdf_url":null,"source":{"id":"https://openalex.org/S59378366","display_name":"Clinical Trials","issn_l":"1740-7745","issn":["1740-7745","1740-7753"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Trials","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2977278673","https://openalex.org/W4409822404","https://openalex.org/W3177708185","https://openalex.org/W3083073081","https://openalex.org/W2891966611","https://openalex.org/W3029214648","https://openalex.org/W3105797051","https://openalex.org/W3203159507","https://openalex.org/W2512433945","https://openalex.org/W2896626889"],"abstract_inverted_index":{"Background:":[0],"Human":[1],"cancers":[2],"are":[3,133],"associated":[4],"with":[5,35,46,120,145,174,239,244,304,452],"defects":[6],"in":[7,21,51,56,80,308,395,407,417,449],"DNA":[8,24],"damage":[9,25],"repair":[10,457],"(DDR).":[11],"Evidence":[12],"suggests":[13],"a":[14,121,245],"key":[15,365],"role":[16],"for":[17,33,108,138,364,478],"poly(ADP-ribose)":[18],"polymerases":[19],"(PARPs)":[20],"repairing":[22],"certain":[23],"lesions.":[26],"Olaparib":[27,74,448],"(a":[28],"PARP":[29,72],"inhibitor)":[30],"is":[31,264,346,415],"approved":[32],"pts":[34,45,115,155,173,238,259,390],"germline":[36],"BRCA1":[37,61,246,265],"and":[38,41,44,64,86,186,252,269,312,351,374,399,404,411],"BRCA2-mutated":[39],"breast":[40,251],"ovarian":[42,53,253],"cancers,":[43,83],"or":[47,62,136,164,184,208,247,266,294,320,460],"without":[48,177],"BRCA":[49],"mutation":[50,249,458],"recurrent":[52],"cancer.":[54],"Mutations":[55],"HRR":[57,219],"genes":[58],"(HRRm;":[59],"beyond":[60],"BRCA2)":[63],"HRD":[65],"may":[66,198],"sensitize":[67],"tumors":[68],"to":[69,71,93,104,326],"respond":[70],"inhibitors.":[73],"has":[75],"also":[76,157],"shown":[77],"favorable":[78],"ORRs":[79],"HRRm/HRD-positive":[81],"(HRD+)":[82],"including":[84],"prostate":[85,175],"ovarian.":[87],"Thus,":[88],"this":[89,109],"study":[90,113,295,470],"(NCT03742895)":[91],"aims":[92],"evaluate":[94],"the":[95,217,309,348,356,380,475],"use":[96],"of":[97,101,118,142,182,203,277,369,371,474],"HRRm/HRD+":[98,126],"as":[99,273],"biomarkers":[100],"tumor-agnostic":[102],"response":[103,305],"olaparib":[105,283],"monotherapy.Methods:":[106],"Eligibility":[107],"open-label,":[110],"Phase":[111,467],"II":[112,468],"requires":[114],"\u226518":[116],"years":[117],"age":[119],"previously":[122,453],"treated,":[123,454],"histologically/cytologically":[124],"confirmed,":[125],"advanced":[127,465],"solid":[128,241],"tumor;":[129],"who":[130],"have":[131,158,199],"failed,":[132],"intolerant":[134],"to,":[135],"ineligible":[137],"all":[139],"available":[140],"standard":[141],"care":[143],"therapies;":[144],"no":[146,187],"disease":[147,160,290],"progression":[148],"during":[149],"prior":[150,194,204],"platinum-based":[151],"treatment.":[152],"At":[153],"baseline,":[154,303],"should":[156],"measurable":[159],"per":[161,315,331],"RECIST":[162,170,316,322],"v1.1":[163,171,317],"Prostate":[165],"Cancer":[166,479,493],"Working":[167],"Group":[168],"(PCWG)-modified":[169],"(for":[172],"cancer)":[176],"CNS":[178],"metastases,":[179],"ECOG":[180],"PS":[181],"0":[183],"1,":[185],"persistent":[188],"toxicities":[189],"(CTCAE":[190],"grade":[191],">2)":[192],"from":[193],"cancer":[195],"therapy.":[196],"Pts":[197,227,280],"received":[200],"any":[201,240],"number":[202],"regimens.":[205],"Newly":[206],"obtained":[207],"archival":[209],"tumor":[210,242,261],"samples":[211],"will":[212,228,236,257,281,299,336,359,376,385,391],"be":[213,229,300,337,360,377,386,392],"centrally":[214],"evaluated":[215],"using":[216,339,355,379],"Lynparza":[218],"Assay":[220],"(under":[221],"development":[222],"at":[223,302],"Foundation":[224],"Medicine,":[225],"Inc).":[226],"grouped":[230],"into":[231],"2":[232,256,409],"cohorts:":[233],"cohort":[234,255,396,408],"1":[235,397],"include":[237,258],"type":[243],"BRCA2":[248,267,400,412],"(excluding":[250],"cancers);":[254],"whose":[260],"(any":[262],"type)":[263],"wild-type":[268],"HRRm":[270,403],"and/or":[271],"HRD+":[272,406],"determined":[274],"by":[275,318],"loss":[276],"heterozygosity":[278],"score.":[279],"receive":[282],"300":[284],"mg":[285],"orally":[286],"BID":[287],"until":[288],"documented":[289],"progression,":[291],"unacceptable":[292],"toxicity,":[293],"withdrawal.":[296],"Tumor":[297],"imaging":[298],"performed":[301],"assessments":[306],"Q8W":[307],"first":[310],"year":[311],"Q12W":[313],"thereafter,":[314],"BICR":[319],"PCWG-modified":[321],"v1.1,":[323],"both":[324],"modified":[325],"follow":[327],"\u22645":[328],"target":[329],"lesions":[330],"organ":[332],"(10":[333],"total).":[334],"AEs":[335],"graded":[338],"NCI":[340],"CTCAE":[341],"v4.0.":[342],"The":[343],"primary":[344],"endpoint":[345],"ORR;":[347],"point":[349],"estimate":[350],"95%":[352],"CI":[353],"calculated":[354],"Clopper-Pearson":[357],"method":[358],"provided.":[361],"Summary":[362],"statistics":[363],"secondary":[366],"efficacy":[367],"endpoints":[368,384],"duration":[370],"response,":[372],"OS,":[373],"PFS":[375],"provided":[378],"Kaplan-Meier":[381],"method.":[382],"Safety":[383],"summarized.":[387],"Approximately":[388],"370":[389],"enrolled":[393],"(~84":[394],"[BRCA1":[398,410],"mutated];":[401],"~174":[402],"~112":[405],"wild-type]).":[413],"Enrollment":[414],"ongoing":[416],"5":[418],"countries":[419],"beginning":[420],"December":[421],"12,":[422],"2018.Citation":[423],"Format:":[424],"David":[425],"Hyman,":[426],"Andrew":[427],"Hendifar,":[428],"Hyun":[429],"Cheol":[430],"Chung,":[431],"Michele":[432],"Maio,":[433],"Alexandra":[434],"Leary,":[435],"Iben":[436],"Spanggaard,":[437],"Joon":[438],"Rhee,":[439],"Matt":[440],"Marton,":[441],"Menghui":[442],"Chen,":[443],"Suba":[444],"Krishnan,":[445],"Ronnie":[446],"Shapira.":[447],"patients":[450],"(pts)":[451],"homologous":[455,461],"recombination":[456,462],"(HRRm)":[459],"deficiency":[463],"(HRD)-positive":[464],"cancer:":[466],"LYNK-002":[469],"[abstract].":[471],"In:":[472],"Proceedings":[473],"American":[476],"Association":[477],"Research":[480],"Annual":[481],"Meeting":[482],"2019;":[483],"2019":[484],"Mar":[485],"29-Apr":[486],"3;":[487],"Atlanta,":[488],"GA.":[489],"Philadelphia":[490],"(PA):":[491],"AACR;":[492],"Res":[494],"2019;79(13":[495],"Suppl):Abstract":[496],"nr":[497],"CT229.":[498]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2022-05-11T00:00:00"}